Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Ping Chi(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Li‐Xuan Qin(Memorial Sloan Kettering Cancer Center), Cindy J. Lee(Memorial Sloan Kettering Cancer Center), Aimeé M. Crago(Memorial Sloan Kettering Cancer Center), Sinchun Hwang(Memorial Sloan Kettering Cancer Center), Moriah Martindale(Memorial Sloan Kettering Cancer Center), Katherine A. Thornton(Memorial Sloan Kettering Cancer Center), Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Mark A. Dickson(Memorial Sloan Kettering Cancer Center), Benjamin A. Nacev(University of Pittsburgh), Evan Rosenbaum(Memorial Sloan Kettering Cancer Center), Sujana Movva(Memorial Sloan Kettering Cancer Center), Haley T. Phelan(Memorial Sloan Kettering Cancer Center), Mary Louise Keohan(Roche (Switzerland)), Samuel Singer(Memorial Sloan Kettering Cancer Center), Niedzica Camacho(AstraZeneca (United Kingdom)), Ciara M. Kelly(Memorial Sloan Kettering Cancer Center), Cristina R. Antonescu(Memorial Sloan Kettering Cancer Center), Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Jasmine H. Francis(Memorial Sloan Kettering Cancer Center), Yu Chen(Guangdong Academy of Medical Sciences), Matthew D. Biniakewitz(Memorial Sloan Kettering Cancer Center)

Clinical Cancer Research

February 1, 2022

Cited by 16

|Nature|2012|8.5k

|Nature Genetics|2019|4.4k

|Nature|2010|4.1k

|Cell|2015|3.6k

|Cell|2015|3.3k

Related Papers